Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Paroxetine for the treatment of interferon‐α‐induced depression in chronic hepatitis C

Kraus, M. R., Schäfer, A., Faller, H., Csef, H., Scheurlen, M. · 2002 · Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background : Psychiatric side‐effects may require dose reduction or premature discontinuation of interferon therapy in chronic hepatitis C. New strategies are needed in order to prevent the premature termination of interferon therapy. Aim : To evaluate prospectively the efficacy and tolerability of antidepressant therapy (paroxetine, a selective serotonin reuptake inhibitor) in patients with chronic hepatitis C treated with interferon‐α who have developed interferon‐induced major depression. Methods : A sub‐group of 14 individuals from 121 consecutively treated hepatitis C patients developed substance‐induced major depression without suicidal ideation during interferon‐α treatment. The individuals in this sub‐group received paroxetine after the occurrence of depression (20 mg daily until termination of interferon therapy). Diagnostic scores for depression (and anger–hostility) were obtained in a repeated measures design (Hospital Anxiety and Depression Scale and Symptom Checklist 90 Items Revised). Results : Eleven of the 14 patients (78.6%) with interferon‐induced major depression were able to complete interferon‐α therapy as scheduled under concomitant paroxetine treatment (three dropouts: insufficient improvement of depression, occurrence of epileptic seizures, paroxetine‐induced nausea/dizziness). Within 4 weeks after the start of paroxetine medication, depression scores declined significantly in all patients. Conclusions : Our data suggest that concomitant therapy with paroxetine is an effective way to treat interferon‐induced depression in patients with chronic hepatitis C.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.2002.01265.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 170

Metadata

Authors
Kraus, M. R., Schäfer, A., Faller, H., Csef, H., & Scheurlen, M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2002-05-27
Volume
16
Issue
6
Pages
1091-1099
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1966509200
Cited by
170
References
1
FWCI
11.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Paroxetine for the treatment of interferon‐α‐induced depression in chronic hepatitis C. https://app.cochat.ai/papers/10.1046/j.1365-2036.2002.01265.x
The paper
Kraus, M. R., Schäfer, A., Faller, H., Csef, H., & Scheurlen, M. (2002). Paroxetine for the treatment of interferon‐α‐induced depression in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.2002.01265.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.